Climb Bio, Inc. CLYM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$59.85M+19.0% | -$73.9M-110% | -$35.12M+22.4% | -$45.24M+4.7% | ||
| $97K— | —— | —— | —— | ||
| $8.05M+44.9% | $5.56M-56.6% | $12.81M+83.2% | $6.99M+87.1% | ||
| -$54.36M-249% | -$15.56M— | —— | -$37.37M-3.6% | ||
| —— | —— | —— | —— | ||
| —— | $4.65M— | —— | —— | ||
| —— | -$121.09M-272% | $70.58M+105% | $34.44M+130% | ||
| -$21K-100% | $130.73M+15,444% | $841K— | $0-100% | ||
| —— | -$5.88M-112% | $49.53M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Climb Bio, Inc. generate?
- Climb Bio, Inc. (CLYM) generated -$53.3M in operating cash flow over the trailing twelve months.
- What is Climb Bio, Inc.'s free cash flow?
- After $109.0K of capital expenditures, Climb Bio, Inc.'s free cash flow was -$41.0M over the trailing twelve months.
- Where does Climb Bio, Inc.'s cash flow data come from?
- Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.